Brazil - Severe Acute Respiratory Syndrome Database - including data from COVID-19 2020-2022
Severe Acute Respiratory Syndrome Database - including COVID-19 data
COVID-19
Dataset Records for COVID-19
Displaying 801 - 850 of 1560
Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
GHDx Entry last modified on: Jan 31, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit
GHDx Entry last modified on: Jan 31, 2024
Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection
GHDx Entry last modified on: Jan 31, 2024
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
Seroepidemiology of SARS-CoV-2 infections in an urban Nicaraguan population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020
GHDx Entry last modified on: Jan 31, 2024
Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19
GHDx Entry last modified on: Apr 10, 2023
The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic
GHDx Entry last modified on: Jun 5, 2024
Body Composition in Community-Dwelling Older Adults Before and After SARS-CoV-2 Infection: A Longitudinal Prospective Study in a Rural Village Struck by the Pandemic
GHDx Entry last modified on: Mar 14, 2022
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020
GHDx Entry last modified on: Jan 31, 2024
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey
GHDx Entry last modified on: Feb 29, 2024
United Kingdom - England and Wales Deaths Registered Weekly 2022
Deaths registered weekly in England and Wales, provisional
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals. Preprint
GHDx Entry last modified on: Apr 14, 2022
Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City
GHDx Entry last modified on: Jan 31, 2024
Initial findings of universal screening for SARS-CoV-2 in women admitted for delivery in North Wales: a prospective multicentre cohort study
GHDx Entry last modified on: Jan 31, 2024
Coronavirus disease 2019 infection and placental histopathology in women delivering at term
GHDx Entry last modified on: Jan 31, 2024
Maternal death due to COVID-19
GHDx Entry last modified on: Apr 10, 2023
Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT
GHDx Entry last modified on: Mar 22, 2024
Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study
GHDx Entry last modified on: Mar 22, 2024
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews
GHDx Entry last modified on: Mar 22, 2024
Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier
GHDx Entry last modified on: Mar 22, 2024
Effect of Different Factors on the Quality of Life and Sequelae of COVID-19 Patients after Discharge
GHDx Entry last modified on: Mar 22, 2024
Development Assistance for Health on COVID-19 Database 2020-2022
GHDx Entry last modified on: Jul 31, 2024
Development Assistance for Health on COVID-19 Database 2020-2023
GHDx Entry last modified on: Jul 31, 2024
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
GHDx Entry last modified on: Jan 31, 2024
The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the State of Maranhao, Brazil. Preprint
GHDx Entry last modified on: May 12, 2022
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort
GHDx Entry last modified on: Jan 31, 2024
Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with Coronavirus Disease 2019 in New York City
GHDx Entry last modified on: Jan 31, 2024
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain
GHDx Entry last modified on: Mar 14, 2022
Clinical Implications of SARS-CoV-2 Infection in the Viable Preterm Period
GHDx Entry last modified on: Jan 31, 2024
A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization
GHDx Entry last modified on: Jan 31, 2024
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey
GHDx Entry last modified on: May 12, 2022
[Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic]
Популяционный имм унитет к SARS-CoV-2 среди населения Санкт-Петербурга в период эпидемии COVID-19
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
[Distribution of SARS-CоV-2 seroprevalence among residents of the Republic of Tatarstan during the COVID-19 epidemic period]
Характеристика серопревалентности к SARS-СoV-2 среди населения Республики Татарстан на фоне COVID-19
SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
GHDx Entry last modified on: May 12, 2022
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
GHDx Entry last modified on: Jan 31, 2024
Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China
GHDx Entry last modified on: Mar 14, 2022
Subscribe